This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
class i | 2215 |
mhc class | 1746 |
class ii | 1223 |
immune response | 754 |
dendritic cells | 524 |
major histocompatibility | 459 |
immune system | 457 |
immune responses | 436 |
histocompatibility complex | 408 |
cell epitopes | 397 |
amino acid | 385 |
antigen presentation | 379 |
i molecules | 361 |
cell surface | 350 |
cell receptor | 321 |
amino acids | 300 |
cell responses | 286 |
mhc i | 284 |
cd cd | 262 |
mhc molecules | 249 |
cell lines | 243 |
virus infection | 241 |
cell epitope | 236 |
peripheral blood | 226 |
bone marrow | 225 |
gene expression | 216 |
cell activation | 214 |
i mhc | 211 |
antigen processing | 211 |
ii mhc | 208 |
multiple sclerosis | 196 |
specific cd | 193 |
flow cytometry | 192 |
nervous system | 188 |
endoplasmic reticulum | 188 |
hla class | 183 |
cell response | 183 |
cell line | 179 |
cell clones | 178 |
peptide binding | 161 |
ii molecules | 161 |
cell death | 160 |
complex class | 159 |
central nervous | 158 |
type i | 157 |
presenting cells | 151 |
epitope prediction | 150 |
binding affinity | 150 |
cd cells | 150 |
dna vaccine | 145 |
infected cells | 145 |
graft survival | 144 |
viral infection | 141 |
antigen expression | 140 |
endothelial cells | 138 |
nk cells | 138 |
i expression | 137 |
transgenic mice | 134 |
innate immune | 133 |
epithelial cells | 133 |
adaptive immune | 130 |
cell proliferation | 128 |
influenza virus | 128 |
immunodeficiency virus | 125 |
tumor cells | 123 |
necrosis factor | 122 |
mhc ii | 117 |
dengue virus | 116 |
data suggest | 116 |
cell types | 115 |
viral infections | 115 |
surface expression | 115 |
significantly higher | 114 |
may also | 113 |
important role | 112 |
high levels | 112 |
transplant recipients | 112 |
dendritic cell | 110 |
dna vaccines | 110 |
i antigen | 109 |
vaccine design | 108 |
human immunodeficiency | 107 |
ng ml | 107 |
cord uid | 106 |
doc id | 106 |
present study | 105 |
cytokine production | 105 |
tumor necrosis | 104 |
monoclonal antibodies | 104 |
lymph nodes | 103 |
acute rejection | 102 |
i alleles | 101 |
deficient mice | 98 |
cell recognition | 96 |
binding peptides | 93 |
natural killer | 93 |
mast cells | 93 |
nkt cells | 93 |
antigen presenting | 92 |
nk cell | 92 |
population coverage | 92 |
vaccine development | 91 |
rhesus macaques | 91 |
target cells | 91 |
signal transduction | 90 |
mhc antigen | 90 |
virus type | 89 |
virus replication | 89 |
specific ctl | 89 |
antibody response | 88 |
immune cells | 87 |
wild type | 87 |
respiratory syndrome | 87 |
er membrane | 86 |
monoclonal antibody | 85 |
results suggest | 85 |
vaccinia virus | 84 |
innate immunity | 84 |
autoimmune diseases | 83 |
like receptor | 83 |
autoimmune disease | 82 |
infectious diseases | 81 |
previously described | 81 |
cell receptors | 80 |
adaptive immunity | 80 |
viral proteins | 79 |
i binding | 79 |
inflammatory response | 78 |
mrna expression | 78 |
ctl response | 78 |
i molecule | 77 |
kidney transplant | 77 |
herpes simplex | 77 |
host immune | 77 |
mononuclear cells | 76 |
genetic diversity | 76 |
cell repertoire | 76 |
human papillomavirus | 75 |
membrane protein | 75 |
positive cells | 74 |
performed using | 74 |
ebola virus | 74 |
heavy chain | 73 |
basic protein | 73 |
molecular mimicry | 73 |
cell subsets | 73 |
infected mice | 73 |
mhc antigens | 72 |
viral replication | 72 |
hepatitis virus | 71 |
myelin basic | 71 |
host cell | 71 |
adhesion molecules | 71 |
ii binding | 70 |
mhc binding | 70 |
plasmid dna | 70 |
protein sequences | 70 |
acute respiratory | 69 |
glial cells | 69 |
ex vivo | 69 |
effector cells | 68 |
th cells | 68 |
inkt cells | 68 |
lymph node | 68 |
stem cells | 68 |
nitric oxide | 68 |
protein expression | 67 |
expressing cells | 67 |
cells expressing | 67 |
simplex virus | 67 |
renal function | 66 |
intracellular pathogens | 66 |
ctl epitopes | 66 |
human cytomegalovirus | 66 |
cell population | 66 |
mouse model | 66 |
bl mice | 65 |
bnp dams | 65 |
mhc expression | 65 |
ii alleles | 65 |
i genes | 65 |
transcription factor | 65 |
antigen recognition | 65 |
dependent manner | 64 |
clinical trials | 64 |
growth factor | 64 |
liver transplantation | 64 |
spleen cells | 64 |
severe acute | 64 |
mouse hepatitis | 63 |
cell development | 63 |
significantly lower | 63 |
signal peptide | 63 |
antibody responses | 63 |
binding site | 63 |
like receptors | 62 |
may contribute | 62 |
inflammatory cytokines | 62 |
highly conserved | 62 |
pg ml | 61 |
ii expression | 61 |
virus infections | 61 |
neutralizing antibodies | 61 |
graft function | 60 |
drb alleles | 60 |
sertoli cells | 60 |
graft loss | 60 |
ctl responses | 60 |
cell populations | 60 |
chronic rejection | 59 |
mhc molecule | 59 |
additional file | 59 |
target cell | 59 |
peptide vaccine | 59 |
presentation pathway | 59 |
antigenic peptides | 59 |
ii antigen | 58 |
previous studies | 58 |
renal transplant | 58 |
barr virus | 58 |
molecular mechanisms | 57 |
determine whether | 57 |
ctl escape | 57 |
human cd | 57 |
salt bridge | 57 |
low levels | 57 |
binding prediction | 56 |
infectious virus | 56 |
human mhc | 56 |
mg kg | 56 |
disease virus | 55 |
escape mutants | 55 |
allograft rejection | 55 |
viral antigens | 55 |
cell differentiation | 55 |
cells may | 54 |
control group | 54 |
based vaccine | 54 |
kidney transplantation | 54 |
recombinant protein | 54 |
cellular immune | 54 |
adhesion molecule | 53 |
expression levels | 53 |
rabies virus | 53 |
cell function | 53 |
apoptotic cells | 53 |
rna viruses | 53 |
data indicate | 53 |
positive selection | 52 |
viral rna | 52 |
western blot | 52 |
cell cycle | 52 |
nipah virus | 52 |
host cells | 52 |
cd expression | 52 |
synthetic peptides | 51 |
specific immune | 51 |
significantly reduced | 51 |
protective immunity | 51 |
results indicate | 51 |
dna vaccination | 51 |
cell type | 51 |
plasma membrane | 51 |
vg vd | 50 |
animal models | 50 |
immune surveillance | 50 |
mg dl | 50 |
bvd vaccinated | 50 |
gene products | 49 |
human leukocyte | 49 |
vaccine candidates | 49 |
subunit vaccines | 49 |
least one | 49 |
protein kinase | 49 |
may play | 49 |
protein sequence | 49 |
i antigens | 49 |
acid sequence | 48 |
signaling pathways | 48 |
helper cells | 48 |
bat mhc | 48 |
memory cd | 48 |
long term | 48 |
large number | 48 |
autophagy proteins | 48 |
mediated rejection | 48 |
quality control | 48 |
i heavy | 48 |
stem cell | 48 |
allergic encephalomyelitis | 47 |
tlr ligands | 47 |
experimental allergic | 47 |
two different | 47 |
also known | 47 |
envelope protein | 47 |
cells specific | 47 |
allograft survival | 47 |
immune epitope | 46 |
sequence alignment | 46 |
west nile | 46 |
cd foxp | 46 |
mhc complexes | 46 |
mice immunized | 46 |
central role | 46 |
recent studies | 46 |
transcription factors | 46 |
ubiquitin ligase | 45 |
mass spectrometry | 45 |
montanide isa | 45 |
heat shock | 45 |
specific cytotoxic | 45 |
gene delivery | 45 |
leukocyte antigen | 45 |
mast cell | 45 |
first time | 45 |
healthy controls | 45 |
plasma cells | 45 |
hla alleles | 45 |
significantly increased | 45 |
immune evasion | 44 |
high affinity | 44 |
previously shown | 44 |
neutralizing antibody | 44 |
ml min | 44 |
serum creatinine | 44 |
wide range | 44 |
adoptive transfer | 44 |
antigenic peptide | 44 |
humoral immune | 43 |
brain barrier | 43 |
mice infected | 43 |
proinflammatory cytokines | 43 |
patient survival | 43 |
cell mediated | 42 |
analyzed using | 42 |
vaccine candidate | 42 |
cells express | 42 |
protein synthesis | 42 |
blood mononuclear | 42 |
gene therapy | 42 |
associated degradation | 42 |
epitope database | 42 |
surface molecules | 42 |
endothelial cell | 42 |
taken together | 42 |
costimulatory molecules | 42 |
cells within | 42 |
microglial cells | 42 |
mycobacterium tuberculosis | 42 |
mediated immune | 42 |
ii mrna | 42 |
mhc genes | 42 |
critical role | 42 |
high level | 42 |
peptide complexes | 42 |
risk factors | 42 |
even though | 41 |
reverse vaccinology | 41 |
family members | 41 |
days post | 41 |
syndrome coronavirus | 41 |
rhesus macaque | 41 |
binding motifs | 41 |
two groups | 41 |
crystal structure | 41 |
type ii | 41 |
producing cells | 41 |
immunized mice | 41 |
tg mice | 41 |
viral peptides | 41 |
chinese rhesus | 41 |
molecular weight | 41 |
antiviral immunity | 40 |
specific antibodies | 40 |
predicted epitopes | 40 |
closely related | 40 |
com scientificreports | 40 |
i peptide | 40 |
time points | 40 |
sequence similarity | 40 |
also observed | 40 |
positional bias | 40 |
hemorrhagic fever | 40 |
increased expression | 39 |
acid sequences | 39 |
virus glycoprotein | 39 |
results demonstrate | 39 |
cell antigen | 39 |
i ifn | 39 |
mer peptides | 39 |
immune recognition | 39 |
based vaccines | 39 |
disease progression | 39 |
hiv infection | 39 |
prediction methods | 39 |
transplant patients | 39 |
blood samples | 38 |
data show | 38 |
infectious agents | 38 |
disulfide isomerase | 38 |
germ cells | 38 |
mycobacterium avium | 38 |
genetic variation | 38 |
peptide presentation | 38 |
peptide loading | 38 |
balancing selection | 38 |
blot analysis | 38 |
i presentation | 38 |
differentially expressed | 38 |
control groups | 38 |
mhc complex | 38 |
virus release | 38 |
cell membrane | 38 |
web server | 38 |
different mhc | 38 |
liver transplant | 37 |
fc receptor | 37 |
protein antigens | 37 |
lymphocyte responses | 37 |
results show | 37 |
may lead | 37 |
peptides derived | 37 |
langerhans cells | 37 |
dna constructs | 37 |
cell immunity | 37 |
gene product | 37 |
tumor growth | 37 |
cell clone | 37 |
mediated immunity | 37 |
fold increase | 37 |
recognition receptors | 37 |
molecular dynamics | 37 |
crucial role | 37 |
delivery systems | 36 |
protective immune | 36 |
transporter associated | 36 |
knockout mice | 36 |
immune cell | 36 |
protein disulfide | 36 |
time pcr | 36 |
may provide | 36 |
facs analysis | 36 |
human hla | 36 |
side effects | 36 |
peptide sequences | 36 |
molecular docking | 36 |
significant increase | 36 |
killer cells | 36 |
invariant chain | 36 |
chicken mhc | 36 |
acid residues | 36 |
chronic inflammatory | 36 |
ii antigens | 36 |
hla molecules | 36 |
heavy chains | 36 |
higher levels | 36 |
healthy donors | 35 |
key role | 35 |
ko mice | 35 |
sertoli cell | 35 |
peptide ligands | 35 |
sequence analysis | 35 |
single amino | 35 |
binding protein | 35 |
stranded rna | 35 |
draining lymph | 35 |
significant difference | 35 |
graft rejection | 35 |
encephalitis virus | 35 |
toxoplasma gondii | 35 |
differential expression | 35 |
membrane proteins | 34 |
ii presentation | 34 |
ii genes | 34 |
genes involved | 34 |
sendai virus | 34 |
infected patients | 34 |
synthetic peptide | 34 |
cancer cells | 34 |
express class | 34 |
host defense | 34 |
protein degradation | 34 |
express mhc | 34 |
highly immunogenic | 34 |
measles virus | 34 |
dtg mice | 34 |
binding groove | 34 |
significant differences | 34 |
antibody production | 34 |
cellular immunity | 33 |
tissue culture | 33 |
lymphocytic choriomeningitis | 33 |
mhc alleles | 33 |
proteasome system | 33 |
cytokine secretion | 33 |
cell culture | 33 |
i restricted | 33 |
inflammatory bowel | 33 |
epitope mapping | 33 |
adaptor protein | 33 |
three different | 33 |
virus particles | 33 |
antigen receptor | 33 |
ctl clones | 33 |
associated protein | 33 |
nile virus | 33 |
type mice | 33 |
pattern recognition | 33 |
autoimmune encephalomyelitis | 33 |
antigen specific | 32 |
gene transfer | 32 |
autophagy pathway | 32 |
poorly understood | 32 |
organ transplantation | 32 |
inflammatory cells | 32 |
phase i | 32 |
bat species | 32 |
limiting dilution | 32 |
donor age | 32 |
mrna levels | 32 |
binding sites | 32 |
infected astrocytes | 32 |
immune complexes | 32 |
two distinct | 32 |
previously reported | 31 |
progenitor cells | 31 |
protein folding | 31 |
negative selection | 31 |
total rna | 31 |
flow cytometric | 31 |
i hla | 31 |
hexavalent recombinant | 31 |
aa insertion | 31 |
room temperature | 31 |
mg ml | 31 |
human peripheral | 31 |
peptide complex | 31 |
sequence homology | 31 |
nucleic acids | 31 |
viral epitopes | 31 |
ii major | 31 |
tcr repertoire | 31 |
bd biosciences | 31 |
structural proteins | 31 |
genes encoding | 31 |
viral antigen | 31 |
specific antibody | 31 |
mice showed | 31 |
animal model | 30 |
signaling pathway | 30 |
derived peptides | 30 |
proteasomal degradation | 30 |
results showed | 30 |
analysis resource | 30 |
derived dendritic | 30 |
mammalian cells | 30 |
first step | 30 |
infected cell | 30 |
mouse strains | 30 |
one year | 30 |
nkt cell | 30 |
graft failure | 30 |
shock protein | 30 |
ctl activity | 30 |
fc receptors | 30 |
spinal cord | 30 |
cd mab | 30 |
human populations | 29 |
recombinant proteins | 29 |
western blotting | 29 |
also found | 29 |
serum levels | 29 |
cells also | 29 |
seminiferous epithelium | 29 |
signal peptides | 29 |
cells infected | 29 |
major role | 29 |
treg cells | 29 |
protein structure | 29 |
cells showed | 29 |
cynomolgus macaques | 29 |
heparan sulfate | 29 |
specific ctls | 29 |
proteasomal cleavage | 29 |
ctl epitope | 29 |
polymerase chain | 29 |
binding affinities | 29 |
hydrogen bonds | 29 |
cell adhesion | 29 |
systemic lupus | 29 |
intracellular bacteria | 29 |
ii epitopes | 29 |
cell biology | 28 |
foreign antigens | 28 |
stimulatory molecules | 28 |
different cell | 28 |
papillomavirus type | 28 |
cells via | 28 |
vaccinated non | 28 |
viral protein | 28 |
human dendritic | 28 |
statistically significant | 28 |
renal allograft | 28 |
antibody titers | 28 |
negative control | 28 |
autoimmune responses | 28 |
fever virus | 28 |
white matter | 28 |
i major | 28 |
chain reaction | 28 |
type diabetes | 28 |
many different | 28 |
cervical cancer | 28 |
fusion protein | 28 |
cell tolerance | 28 |
cell survival | 28 |
antibody levels | 28 |
growth factors | 28 |
cd cell | 27 |
determined using | 27 |
inflammatory responses | 27 |
linear epitopes | 27 |
lymphoid organs | 27 |
inflammatory diseases | 27 |
pivotal role | 27 |
male reproductive | 27 |
inflammatory mediators | 27 |
novel coronavirus | 27 |
processing pathway | 27 |
rna polymerase | 27 |
term survival | 27 |
survival rates | 27 |
brain injury | 27 |
transgenic mouse | 27 |
immunogenic epitopes | 27 |
epitopes using | 27 |
reperfusion injury | 27 |
gag processing | 27 |
cell cultures | 27 |
based peptide | 27 |
clones specific | 27 |
experimental autoimmune | 27 |
islet allograft | 27 |
single cell | 27 |
memory cells | 27 |
immune escape | 27 |
months post | 27 |
cells stimulated | 27 |
renal transplantation | 27 |
cells play | 27 |
mechanisms involved | 27 |
proliferative response | 27 |
murine model | 27 |
treated mice | 27 |
choriomeningitis virus | 27 |
analysis revealed | 27 |
specific antigen | 27 |
intercellular adhesion | 27 |
total number | 27 |
brain cells | 27 |
bowel disease | 27 |
genomic dna | 27 |
reproductive tract | 27 |
naturally occurring | 27 |
tolerance induction | 27 |
least two | 27 |
molecular basis | 27 |
high degree | 27 |
effector functions | 27 |
leydig cells | 27 |
ischemia reperfusion | 27 |
peptide sequence | 27 |
survival rate | 27 |
prediction tool | 27 |
data demonstrate | 27 |
molecular biology | 26 |
adoptively transferred | 26 |
gamma interferon | 26 |
peptide peptidase | 26 |
inflammatory cytokine | 26 |
subcellular location | 26 |
liver disease | 26 |
antigenic determinants | 26 |
listeria monocytogenes | 26 |
er lumen | 26 |
highest binding | 26 |
lupus erythematosus | 26 |
cells recognize | 26 |
interferon gamma | 26 |
apoptotic cell | 26 |
potential role | 26 |
wt mice | 26 |
mhc peptide | 26 |
signal sequences | 26 |
cell infiltration | 26 |
transfected cells | 26 |
may represent | 26 |
viral vectors | 26 |
dimensional structure | 26 |
ubiquitin ligases | 26 |
gag retention | 26 |
protein mixture | 26 |
prediction method | 26 |
mhc diversity | 26 |
induced apoptosis | 26 |
similar results | 26 |
human blood | 26 |
mice expressing | 26 |
coronavirus infection | 26 |
also used | 26 |
exogenous antigens | 26 |
binding predictions | 26 |
viral gene | 26 |
limited number | 26 |
patients received | 26 |
significantly decreased | 26 |
stimulating factor | 26 |
cytokine profile | 25 |
reactive oxygen | 25 |
marrow cells | 25 |
positive control | 25 |
produce il | 25 |
inflammatory processes | 25 |
th cytokines | 25 |
nadph oxidase | 25 |
several studies | 25 |
viral load | 25 |
blood lymphocytes | 25 |
vaccinated dams | 25 |
yellow fever | 25 |
misfolded proteins | 25 |
mhc products | 25 |
persistent infection | 25 |
mhc gene | 25 |
years ago | 25 |
statistical analysis | 25 |
i ii | 25 |
infected individuals | 25 |
may result | 25 |
united states | 25 |
cmv infection | 25 |
influenza viruses | 25 |
chronic allograft | 25 |
human monocytes | 25 |
leukemia virus | 25 |
wide variety | 25 |
killer cell | 25 |
proliferative responses | 25 |
anchor residues | 25 |
autophagosome formation | 25 |
ii drb | 25 |
surface antigens | 25 |
derived cells | 25 |
cytokines il | 25 |
structural basis | 25 |
surface receptors | 25 |
analysis showed | 25 |
leydig cell | 25 |
transforming growth | 25 |
inhibitory effect | 25 |
clonal expansion | 25 |
cell depletion | 25 |
kidney recipients | 25 |
histocompatibility antigens | 25 |
proteins may | 25 |
converting enzyme | 25 |
lymphoid tissue | 25 |
constitutively expressed | 25 |
i gene | 25 |
recombinant vaccinia | 24 |
dc maturation | 24 |
acute infection | 24 |
cell transplantation | 24 |
recombinant human | 24 |
thymic epithelial | 24 |
cells using | 24 |
cholera toxin | 24 |
immune genes | 24 |
cell immune | 24 |
signal sequence | 24 |
lymphocyte activation | 24 |
present antigen | 24 |
helper cell | 24 |
regulatory factor | 24 |
lasv gp | 24 |
escherichia coli | 24 |
diabetes mellitus | 24 |
oxide synthase | 24 |
supplementary table | 24 |
increased levels | 24 |
antiviral activity | 24 |
nucleic acid | 24 |
conserved epitopes | 24 |
i allele | 24 |
dengue hemorrhagic | 24 |
cell hybridomas | 24 |
normal mice | 24 |
different types | 24 |
human population | 24 |
tumor cell | 24 |
human genome | 24 |
human cells | 24 |
blood pressure | 24 |
living donor | 24 |
i interferon | 24 |
might also | 24 |
studies using | 24 |
cytotoxic activity | 24 |
positive correlation | 24 |
immune privilege | 24 |
i pathway | 24 |
nucleocapsid protein | 24 |
hla dr | 24 |
deceased donor | 24 |
donor hd | 24 |
binding peptide | 24 |
following infection | 24 |
cardiac allografts | 24 |
newly synthesized | 23 |
alloantibody binding | 23 |
survival benefit | 23 |
rna interference | 23 |
infectious disease | 23 |
mouse models | 23 |
type iii | 23 |
mer peptide | 23 |
plasmacytoid dendritic | 23 |
respiratory tract | 23 |
transcriptional regulation | 23 |
vaccine delivery | 23 |
igg antibodies | 23 |
epitopes derived | 23 |
regulatory cells | 23 |
avium subsp | 23 |
express cd | 23 |
cell help | 23 |
mechanisms underlying | 23 |
psychiatric disorders | 23 |
surface accessibility | 23 |
may occur | 23 |
increased risk | 23 |
surface markers | 23 |
mm tris | 23 |
healthy individuals | 23 |
induction therapy | 23 |
dna encoding | 23 |
candidate epitopes | 23 |
subcellular localization | 23 |
sequence types | 23 |
antibody mediated | 23 |
autophagy machinery | 23 |
dna delivery | 23 |
surface proteins | 23 |
poly i | 23 |
peptides presented | 23 |
body weight | 23 |
immunoinformatics tools | 23 |
peptides binding | 23 |
programmed cell | 23 |
pdb id | 23 |
donor specific | 23 |
oxidative stress | 23 |
risk factor | 23 |
core protein | 23 |
restricted cytotoxic | 23 |
mouse strain | 23 |
artificial neural | 23 |
neural network | 23 |
high frequency | 23 |
potential vaccine | 23 |
pathogen diversity | 23 |
effector function | 23 |
humoral response | 23 |
life cycle | 22 |
subunit vaccine | 22 |
binding domain | 22 |
expression level | 22 |
genetic variability | 22 |
mycophenolate mofetil | 22 |
predicted using | 22 |
tumour antigens | 22 |
mice lacking | 22 |
mdbk cells | 22 |
secretory pathway | 22 |
virus strains | 22 |
control mice | 22 |
binding energy | 22 |
immune regulation | 22 |
ii peptide | 22 |
silico analysis | 22 |
auf die | 22 |
peptide repertoire | 22 |
i haplotypes | 22 |
effi ciency | 22 |
professional apcs | 22 |
goat anti | 22 |
ns protein | 22 |
sars coronavirus | 22 |
viral particles | 22 |
significantly different | 22 |
myeloid cells | 22 |
oxygen species | 22 |
binding epitopes | 22 |
adaptor proteins | 22 |
antigenic proteins | 22 |
deficient cells | 22 |
genome sequence | 22 |
human brain | 22 |
tyrosine kinase | 22 |
ii gene | 22 |
secondary structure | 22 |
blood monocytes | 22 |
tissue damage | 22 |
blood donors | 22 |
full length | 22 |
surface antigen | 22 |
authors declare | 22 |
selected epitopes | 22 |
testicular macrophages | 22 |
producer cells | 22 |
transfection effi | 22 |
meld score | 22 |
winged bat | 22 |
peptides generated | 21 |
binding region | 21 |
autophagy may | 21 |
three times | 21 |
first line | 21 |
two major | 21 |
whole genome | 21 |
spike protein | 21 |
ms patients | 21 |
indian rhesus | 21 |
protective antigens | 21 |
i surface | 21 |
origin rhesus | 21 |
immunogenic proteins | 21 |
primary human | 21 |
culture supernatants | 21 |
united kingdom | 21 |
cord blood | 21 |
drb gene | 21 |
autoimmune response | 21 |
recent data | 21 |
promiscuity level | 21 |
gel electrophoresis | 21 |
mice treated | 21 |
murine coronavirus | 21 |
nod mice | 21 |
binding proteins | 21 |
proteins involved | 21 |
tumor antigens | 21 |
immunological synapse | 21 |
time point | 21 |
peptides bound | 21 |
cell lymphoma | 21 |
prediction tools | 21 |
epitope vaccine | 21 |
findings suggest | 21 |
conformational epitopes | 21 |
like molecules | 21 |
bipolar disorder | 21 |
persistently infected | 21 |
cell memory | 21 |
allele frequency | 21 |
within days | 21 |
well known | 21 |
salt bridges | 21 |
humoral immunity | 21 |
rna virus | 21 |
using flow | 21 |
neural networks | 21 |
th th | 21 |
widely used | 21 |
related genes | 21 |
like protein | 21 |
viral diseases | 21 |
inducing activity | 21 |
cell activity | 21 |
cd memory | 21 |
mouse brain | 21 |
bacterial infections | 21 |
signalling pathways | 21 |
logistic regression | 21 |
th response | 21 |
lower levels | 21 |
marrow derived | 21 |
negatively charged | 21 |
may help | 21 |
peptide fragments | 21 |
experimental data | 20 |
tap transport | 20 |
hydrogen bond | 20 |
investigated whether | 20 |
pathological conditions | 20 |
gamma delta | 20 |
cell carcinoma | 20 |
real time | 20 |
acid substitutions | 20 |
delivery system | 20 |
glial cell | 20 |
mouse mhc | 20 |
cell level | 20 |
spike glycoprotein | 20 |
glucose tolerance | 20 |
cancer immunotherapy | 20 |
current study | 20 |
cells derived | 20 |
cytokine response | 20 |
cellular rejection | 20 |
infiltrating lymphocytes | 20 |
intramembrane proteolysis | 20 |
altered peptide | 20 |
scientificreports www | 20 |
molecule expression | 20 |
cytokine expression | 20 |
possible role | 20 |
world health | 20 |
restricted epitopes | 20 |
kidney tx | 20 |
blood vessels | 20 |
macrophage activation | 20 |
one month | 20 |
mice deficient | 20 |
demyelinating disease | 20 |
elevated levels | 20 |
better understanding | 20 |
recent years | 20 |
peptide tetramer | 20 |
naturally processed | 20 |
cerebrospinal fluid | 20 |
cd antibodies | 20 |
immunodominant epitope | 20 |
presenting cell | 20 |
highly polymorphic | 20 |
cd rb | 20 |
mhc drb | 20 |
clinical trial | 20 |
peptide vaccines | 20 |
peptide epitopes | 20 |
bioinformatics tools | 20 |
multiple sequence | 20 |
cd ro | 20 |
recently shown | 20 |
cell subset | 20 |
heart transplantation | 20 |
culture medium | 20 |
day post | 20 |
nuclear antigen | 20 |
heart disease | 20 |
different strains | 20 |
freshly isolated | 20 |
cell lysates | 20 |
murine cytomegalovirus | 20 |
predicted binding | 20 |
evidence suggests | 20 |
may act | 20 |
antigenic protein | 20 |
low dose | 20 |
receptor expression | 19 |
tlr ligand | 19 |
shock proteins | 19 |
cytokine signaling | 19 |
emerging infectious | 19 |
processing pathways | 19 |
confocal microscopy | 19 |
also called | 19 |
commonly used | 19 |
interstitial fibrosis | 19 |
cell lysis | 19 |
receptor complex | 19 |
germ cell | 19 |
er stress | 19 |
bacterial infection | 19 |
dr expression | 19 |
mhv strains | 19 |
northern blot | 19 |
dna viruses | 19 |
national institutes | 19 |
significant reduction | 19 |
ii expressing | 19 |
cellular proteins | 19 |
rejection episodes | 19 |
avian influenza | 19 |
acute phase | 19 |
protective effect | 19 |
threshold value | 19 |
indirect pathway | 19 |
vitro studies | 19 |
cell apoptosis | 19 |
patients receiving | 19 |
transmembrane domain | 19 |
binding assays | 19 |
bovine serum | 19 |
human immune | 19 |
time course | 19 |
transcriptional activation | 19 |
promoter activity | 19 |
highly specific | 19 |
liver graft | 19 |
highly expressed | 19 |
overlapping peptides | 19 |
spike peptide | 19 |
cell compartment | 19 |
melanoma cells | 19 |
glycosylation sites | 19 |
hcmv us | 19 |
cells isolated | 19 |
term graft | 19 |
post transplant | 19 |
hematopoietic stem | 19 |
activated cd | 19 |
epitope predictions | 19 |
ii complexes | 19 |
exogenous antigen | 19 |
iedb server | 19 |
iu ml | 19 |
receptor binding | 19 |
allele frequencies | 19 |
conformational changes | 19 |
disulfide bonds | 19 |
intracellular cytokine | 19 |
th responses | 19 |
mean age | 19 |
neural cells | 19 |
epitope specificity | 19 |
cell numbers | 19 |
model system | 19 |
essential role | 19 |
cell stimulation | 19 |
data bank | 19 |
regulatory proteins | 19 |
virulence factor | 19 |
cytotoxic cd | 19 |
donor kidney | 19 |
rheumatoid arthritis | 19 |
specific memory | 19 |
bat transcriptome | 19 |
intracellular pathogen | 19 |
vaccinated mice | 19 |
preliminary results | 19 |
proteolytic cleavage | 19 |
positively charged | 19 |
chronic hepatitis | 19 |
steady state | 18 |
reactive cd | 18 |
peptide antigens | 18 |
protein antigen | 18 |
normal conditions | 18 |
healthy subjects | 18 |
specific primers | 18 |
i epitopes | 18 |
cystic fibrosis | 18 |
allelic diversity | 18 |
ii molecule | 18 |
pred balb | 18 |
patients without | 18 |
elispot assay | 18 |
accessory cells | 18 |
protein structures | 18 |
studies suggest | 18 |
virus clearance | 18 |
multivariate analysis | 18 |
renal allografts | 18 |
studies showed | 18 |
viral immune | 18 |
cd cytotoxic | 18 |
immunosuppressive regimen | 18 |
blood group | 18 |
immune systems | 18 |
i proteins | 18 |
smooth muscle | 18 |
gene transcription | 18 |
epitope sequences | 18 |
nuclear factor | 18 |
selected peptides | 18 |
highly pathogenic | 18 |
outer membrane | 18 |
antibody binding | 18 |
professional antigen | 18 |
eukaryotic cells | 18 |
vaccine constructs | 18 |
er quality | 18 |
persistent infections | 18 |
host response | 18 |
large amounts | 18 |
epitopes identified | 18 |
cysteine proteases | 18 |
cell functions | 18 |
protein data | 18 |
preliminary data | 18 |
cytomegalovirus us | 18 |
cells produce | 18 |
autophagy genes | 18 |
tcr binding | 18 |
renal failure | 18 |
vesicular stomatitis | 18 |
findings indicate | 18 |
erad substrates | 18 |
degradation pathway | 18 |
activated macrophages | 18 |
scid mice | 18 |
cells transfected | 18 |
cells following | 18 |
complement activation | 18 |
previous work | 18 |
vascular endothelial | 18 |
effector memory | 18 |
envelope glycoprotein | 18 |
different stages | 18 |
two alleles | 18 |
cd clones | 18 |
cell growth | 18 |
tap expression | 18 |
low affinity | 18 |
health organization | 18 |
mhc polymorphism | 18 |
restricted cd | 18 |
macrophage colony | 18 |
previous study | 18 |
influenza vaccine | 18 |
gene encoding | 18 |
induced class | 18 |
stomatitis virus | 18 |
apm components | 18 |
domestic cat | 18 |
activated protein | 18 |
immunological memory | 18 |
low level | 18 |
pulmonis infection | 18 |
sle patients | 18 |
may explain | 18 |
transplant centers | 18 |
surface mhc | 18 |
epithelial cell | 18 |
adherent cells | 18 |
research center | 18 |
showed significant | 18 |
expression vector | 18 |
mhc ligands | 18 |
regulatory role | 18 |
fusion proteins | 18 |
axonal injury | 18 |
membrane fusion | 18 |
large numbers | 18 |
node cells | 18 |
lung cancer | 18 |
self antigens | 17 |
lymphoid cells | 17 |
live attenuated | 17 |
predicted epitope | 17 |
unfolded protein | 17 |
mhc mrna | 17 |
transmembrane proteins | 17 |
cultured human | 17 |
factor receptor | 17 |
specific igg | 17 |
i ifns | 17 |
fluorescent protein | 17 |
mice vaccinated | 17 |
graft dysfunction | 17 |
viral titers | 17 |
presented peptides | 17 |
analysis using | 17 |
dependent rna | 17 |
acinonyx jubatus | 17 |
breast cancer | 17 |
calcineurin inhibitors | 17 |
binding scores | 17 |
different time | 17 |
neural stem | 17 |
unpublished data | 17 |
cell migration | 17 |
calculated using | 17 |
light chain | 17 |
signal peptidase | 17 |
ec ii | 17 |
analysis demonstrated | 17 |
inducible nitric | 17 |
cytokine il | 17 |
jhmv infection | 17 |
disease susceptibility | 17 |
clinical studies | 17 |
class iii | 17 |
cd lymphocytes | 17 |
virus strain | 17 |
foxp expression | 17 |
specific receptors | 17 |
transduction pathways | 17 |
microarray analysis | 17 |
acid composition | 17 |
creative commons | 17 |
murine class | 17 |
i epitope | 17 |
waiting list | 17 |
cd th | 17 |
respiratory syncytial | 17 |
host species | 17 |
conservancy analysis | 17 |
operational tolerance | 17 |
molecules involved | 17 |
support vector | 17 |
foxp cells | 17 |
vaccine construct | 17 |
mouse igg | 17 |
study demonstrates | 17 |
middle east | 17 |
inhibitory effects | 17 |
tumor suppressor | 17 |
cd antibody | 17 |
cell killing | 17 |
infection induces | 17 |
may affect | 17 |
stress response | 17 |
secondary lymphoid | 17 |
molecular patterns | 17 |
currently available | 17 |
several different | 17 |
better understand | 17 |
provide evidence | 17 |
animal care | 17 |
intestinal inflammation | 17 |
specific cellular | 17 |
dc activation | 17 |
restricted antigen | 17 |
accession numbers | 17 |
bat influenza | 17 |
tumor development | 17 |
defense mechanisms | 17 |
interferon regulatory | 17 |
lt recipients | 17 |
neurotropic coronavirus | 17 |
specific hla | 17 |
early stages | 17 |
tlr tlr | 17 |
restricted ctl | 17 |
mst days | 17 |
patienten mit | 17 |
candidate genes | 17 |
malignant cells | 17 |
gene family | 17 |
human melanoma | 17 |
immune status | 17 |
alpha beta | 17 |
therapeutic potential | 17 |
university school | 17 |
predictive value | 17 |
heterologous immunity | 17 |
takes place | 17 |
derived macrophages | 17 |
may indicate | 17 |
cell cross | 17 |
charged residues | 17 |
i complexes | 17 |
tlr stimulation | 17 |
bnp calves | 17 |
cell maturation | 17 |
see also | 17 |
mediated cytotoxicity | 17 |
presentation pathways | 17 |
nucleotide sequence | 17 |
remains unclear | 17 |
may involve | 17 |
associated molecular | 17 |
delayed graft | 17 |
cd ko | 17 |
may influence | 17 |
recent advances | 17 |
tcr recognition | 17 |
antibodies directed | 16 |
total igg | 16 |
take place | 16 |
will also | 16 |
biological activity | 16 |
linear epitope | 16 |
er dislocation | 16 |
ligase activity | 16 |
give rise | 16 |
conserved regions | 16 |
autodock vina | 16 |
largely unknown | 16 |
cutting edge | 16 |
peptide ligand | 16 |
results obtained | 16 |
different species | 16 |
long peptides | 16 |
world population | 16 |
protein level | 16 |
renal cell | 16 |
vast majority | 16 |
studies show | 16 |
mouth disease | 16 |
effector cd | 16 |
inbred strains | 16 |
mhc restriction | 16 |
final vaccine | 16 |
vaccine antigens | 16 |
epitopes within | 16 |
immune activation | 16 |
i protein | 16 |
genes associated | 16 |
situ hybridization | 16 |
pei dna | 16 |
specific mhc | 16 |
specific responses | 16 |
simian immunodeficiency | 16 |
lymphocyte epitope | 16 |
physicochemical properties | 16 |
activation markers | 16 |
ifn production | 16 |
identified using | 16 |
syncytial virus | 16 |
autophagic machinery | 16 |
hla supertypes | 16 |
naive cd | 16 |
type virus | 16 |
cell contact | 16 |
antiviral immune | 16 |
east respiratory | 16 |
cytokine receptors | 16 |
recently described | 16 |
severe disease | 16 |
human class | 16 |
extracellular domain | 16 |
mhc region | 16 |
dna sequence | 16 |
peptides recognized | 16 |
less likely | 16 |
small number | 16 |
hla allele | 16 |
hidden markov | 16 |
immune suppression | 16 |
solid organ | 16 |
genomic islands | 16 |
public health | 16 |
expression system | 16 |
may function | 16 |
mice compared | 16 |
mononuclear cell | 16 |
alleles hla | 16 |
cellular responses | 16 |
broad range | 16 |
cns cells | 16 |
allowed us | 16 |
cardiac allograft | 16 |
virus entry | 16 |
rat brain | 16 |
tlr signaling | 16 |
maintenance immunosuppression | 16 |
cell interactions | 16 |
expressing cd | 16 |
adverse effects | 16 |
binding motif | 16 |
relatively low | 16 |
antigen binding | 16 |
cd high | 16 |
tubular atrophy | 16 |
gene segment | 16 |
also demonstrated | 16 |
constitutive expression | 16 |
viral nucleic | 16 |
also play | 16 |
much less | 16 |
brain edema | 16 |
large quantities | 16 |
protein complexes | 16 |
two independent | 16 |
primary infection | 16 |
genetic background | 16 |
crystal structures | 16 |
first year | 16 |
allograft recipients | 16 |
pfu ml | 16 |
plant viruses | 16 |
graft outcome | 16 |
cells increased | 16 |
vgamma vdelta | 16 |
virus envelope | 16 |
tumour necrosis | 16 |
rat testis | 16 |
clinical outcome | 16 |
immune control | 16 |
specific epitopes | 15 |
neglected tropical | 15 |
present data | 15 |
drb locus | 15 |
human coronavirus | 15 |
inflammatory disease | 15 |
igg levels | 15 |
liquid chromatography | 15 |
lysosomal degradation | 15 |
peptide transporter | 15 |
effective immune | 15 |
receptor antagonist | 15 |
epitopes recognized | 15 |
whole blood | 15 |
quantitative real | 15 |
mediated lysis | 15 |
receptor cd | 15 |
direct interaction | 15 |
sequence data | 15 |
secreting cells | 15 |
virus encephalitis | 15 |
also identified | 15 |
fluorescence intensity | 15 |
side chain | 15 |
two types | 15 |
national institute | 15 |
risk hpv | 15 |
dna complexes | 15 |
cell signaling | 15 |
also analyzed | 15 |
derived peptide | 15 |
novel mechanism | 15 |
danger signals | 15 |
specific immunity | 15 |
recipient age | 15 |
peptide motifs | 15 |
predicted mhc | 15 |
dhf dss | 15 |
endocytic pathway | 15 |
inducible expression | 15 |
tight junctions | 15 |
immunoinformatics approach | 15 |
vascular permeability | 15 |
gene gun | 15 |
located within | 15 |
induced cell | 15 |
silico approach | 15 |
viral disease | 15 |
will help | 15 |
weight loss | 15 |
clinical outcomes | 15 |
different mechanisms | 15 |
soluble antigen | 15 |
also shown | 15 |
serum samples | 15 |
different peptides | 15 |
induced colitis | 15 |
common cause | 15 |
functional analysis | 15 |
first months | 15 |
conformational change | 15 |
hematopoietic cells | 15 |
histocompatibility antigen | 15 |
autophagy gene | 15 |
fine specificity | 15 |
derived epitopes | 15 |
immune tolerance | 15 |
kidney transplants | 15 |
wide association | 15 |
lipid rafts | 15 |
cytokine profiles | 15 |
infected animals | 15 |
clinical signs | 15 |
chemokine receptor | 15 |
supplementary material | 15 |
autophagy protein | 15 |
thymic selection | 15 |
protein levels | 15 |
peptide prediction | 15 |
epitopes may | 15 |
cell expansion | 15 |
plasma cell | 15 |
recently reported | 15 |
tlr ko | 15 |
tcr activation | 15 |
cell number | 15 |
proposed epitope | 15 |
following treatment | 15 |
last decade | 15 |
lymphoid tissues | 15 |
dc function | 15 |
chemokine receptors | 15 |
candidate antigens | 15 |
immunol doi | 15 |
stimulated cells | 15 |
clonal deletion | 15 |
least three | 15 |
allograft function | 15 |
virus infected | 15 |
cell cytotoxicity | 15 |
brain tissue | 15 |
clones isolated | 15 |
response elicited | 15 |
loading complex | 15 |
kcal mol | 15 |
ha peptides | 15 |
may reflect | 15 |
borne encephalitis | 15 |
drb loci | 15 |
specific tolerance | 15 |
foxp treg | 15 |
mixed lymphocyte | 15 |
induced expression | 15 |
negative bacteria | 15 |
peptide docking | 15 |
induced autophagy | 15 |
cd ctl | 15 |
candidate vaccine | 15 |
cd molecules | 15 |
cell specific | 15 |
blood flow | 15 |
classical mhc | 15 |
analysed using | 15 |
patients transplanted | 15 |
predicted peptides | 15 |
produce ifn | 15 |
surface protein | 15 |
gene segments | 15 |
sclerosis lesions | 15 |
ligand recognition | 15 |
recent study | 15 |
heart allografts | 14 |
specific antigens | 14 |
tlr activation | 14 |
cell lung | 14 |
cells without | 14 |
mhc rtta | 14 |
melanoma cell | 14 |
ifng production | 14 |
single nucleotide | 14 |
lymphokine production | 14 |
different viruses | 14 |
receptor genes | 14 |
airway inflammation | 14 |
median follow | 14 |
regulate autophagy | 14 |
molecular mechanism | 14 |
jurkat cells | 14 |
signaling molecules | 14 |
expression patterns | 14 |
reverse transcriptase | 14 |
early post | 14 |
ic nm | 14 |
cd effector | 14 |
binding free | 14 |
peptides corresponding | 14 |
islet cell | 14 |
viral entry | 14 |
also examined | 14 |
high binding | 14 |
cd ra | 14 |
location prediction | 14 |
japanese encephalitis | 14 |
ii hla | 14 |
authorship attribution | 14 |
cleavage site | 14 |
kidney cells | 14 |
chronic relapsing | 14 |
cell pool | 14 |
percentile rank | 14 |
natural selection | 14 |
negative regulator | 14 |
dose dependent | 14 |
hypothetical protein | 14 |
cytokine staining | 14 |
much higher | 14 |
immune receptors | 14 |
immunoinformatics approaches | 14 |
ros production | 14 |
expressed cd | 14 |
dominant negative | 14 |
well understood | 14 |
chronic infections | 14 |
cell homeostasis | 14 |
protein database | 14 |
transmembrane domains | 14 |
monocytes macrophages | 14 |
evolutionary history | 14 |
cells bearing | 14 |
peritoneal macrophages | 14 |
single center | 14 |
effective vaccine | 14 |
nude mice | 14 |
ulcerative colitis | 14 |
also showed | 14 |
protein response | 14 |
cytometric analysis | 14 |
two main | 14 |
immune gene | 14 |
foreign antigen | 14 |
bei patienten | 14 |
cytoplasmic domain | 14 |
bound peptide | 14 |
blood cell | 14 |
epitope conservancy | 14 |
head injury | 14 |
well established | 14 |
immune reactions | 14 |
considered significant | 14 |
alloantibody levels | 14 |
leishmania major | 14 |
previously identified | 14 |
third party | 14 |
cd molecule | 14 |
conditioned media | 14 |
strong binding | 14 |
language models | 14 |
acute cellular | 14 |
tissue distribution | 14 |
induced activation | 14 |
conservation scores | 14 |
polyubiquitin chains | 14 |
lamina propria | 14 |
transgenic animals | 14 |
protein epitope | 14 |
vivo gene | 14 |
linked glycosylation | 14 |
ii transactivator | 14 |
clonal selection | 14 |
cerebral blood | 14 |
shock syndrome | 14 |
transcriptional level | 14 |
factor alpha | 14 |
population structure | 14 |
transformed cells | 14 |
lymphocytes secreting | 14 |
precursor protein | 14 |
i interferons | 14 |
immunoinformatic approach | 14 |
generated using | 14 |
chronic inflammation | 14 |
likely due | 14 |
post infection | 14 |
candidate vaccines | 14 |
complex antigen | 14 |
studies indicate | 14 |
double negative | 14 |
antigen cross | 14 |
effi cient | 14 |
structure prediction | 14 |
treated group | 14 |
early stage | 14 |
associated membrane | 14 |
per se | 14 |
cell priming | 14 |
human primates | 14 |
lymphocyte subsets | 14 |
survival time | 14 |
candidate subunit | 14 |
vitro stimulation | 14 |
ctl clone | 14 |
associated antigen | 14 |
neonatal pancytopenia | 14 |
responses induced | 14 |
neuronal cells | 14 |
highly purified | 14 |
foxp tregs | 14 |
signalling pathway | 14 |
supplementary information | 14 |
transport efficiency | 14 |
swine fever | 14 |
tumor antigen | 14 |
nuclear translocation | 14 |
allow us | 13 |
antigenic epitopes | 13 |
virus persistence | 13 |
susceptible mice | 13 |
following transplantation | 13 |
six months | 13 |
recombinant virus | 13 |
structural analysis | 13 |
driven vaccines | 13 |
surface class | 13 |
two genes | 13 |
increased cd | 13 |
highly variable | 13 |
brain parenchyma | 13 |
virus proteins | 13 |
specific cells | 13 |
peptide mhc | 13 |
experiments indicate | 13 |
islet allografts | 13 |
recent evidence | 13 |
medical school | 13 |
highly diverse | 13 |
specific peptide | 13 |
dependent diabetes | 13 |
high concentrations | 13 |
regulatory function | 13 |
low density | 13 |
randomly selected | 13 |
future studies | 13 |
different epitopes | 13 |
cellular processes | 13 |
emini surface | 13 |
stress conditions | 13 |
cpg dna | 13 |
bovine neonatal | 13 |
sensitized patients | 13 |
therapeutic approaches | 13 |
like virus | 13 |
antiviral cd | 13 |
also performed | 13 |
positively selected | 13 |
gene silencing | 13 |
receptor recognition | 13 |
acute encephalitis | 13 |
mediated apoptosis | 13 |
medical center | 13 |
endogenous antigens | 13 |
cancer patients | 13 |
elevated icp | 13 |
cellular location | 13 |
viral dna | 13 |
protein interactions | 13 |
wide spectrum | 13 |
lymphocytic infiltration | 13 |
transduction pathway | 13 |
comparative analysis | 13 |
high risk | 13 |
stable graft | 13 |
htlv i | 13 |
might play | 13 |
extensively studied | 13 |
adult human | 13 |
histocompatibility class | 13 |
cytokine levels | 13 |
loading compartments | 13 |
murine leukemia | 13 |
cell levels | 13 |
pcr products | 13 |
may induce | 13 |
cell infiltrates | 13 |
iedb mhc | 13 |
ii pathway | 13 |
monoclonal anti | 13 |
new vaccines | 13 |
gives rise | 13 |
cell dysfunction | 13 |
ubiquitously expressed | 13 |
well defined | 13 |
cx cr | 13 |
complex molecules | 13 |
experimental evidence | 13 |
alloimmune responses | 13 |
lassa virus | 13 |
limb paralysis | 13 |
ii proteins | 13 |
cytokine responses | 13 |
gtko mcp | 13 |
significant role | 13 |
acid change | 13 |
cell proliferative | 13 |
disease pathogenesis | 13 |
alloreactive cd | 13 |
hace expression | 13 |
prediction using | 13 |
selective pressure | 13 |
candidate proteins | 13 |
adult mice | 13 |
university hospital | 13 |
i ligands | 13 |
clinical symptoms | 13 |
different hla | 13 |
drb sequences | 13 |
specific cell | 13 |
immunodominant peptides | 13 |
signalling molecules | 13 |
geometric mean | 13 |
flavivirus infection | 13 |
tumour cells | 13 |
tcr transgenic | 13 |
current knowledge | 13 |
inhibitory receptors | 13 |
cell lysate | 13 |
nucleotide substitutions | 13 |
cells expressed | 13 |
relatively high | 13 |
spinal cords | 13 |
effector mechanisms | 13 |
allogeneic mhc | 13 |
publicly available | 13 |
first evidence | 13 |
proteolytic activity | 13 |
antigen specificity | 13 |
stabilized matrix | 13 |
expression profile | 13 |
described previously | 13 |
rabbit anti | 13 |
protein peptide | 13 |
cytokine release | 13 |
many viruses | 13 |
murine models | 13 |
map kinase | 13 |
blood cells | 13 |
recently identified | 13 |
results indicated | 13 |
jak stat | 13 |
previously demonstrated | 13 |
transplant model | 13 |
cell suspensions | 13 |
purified cd | 13 |
protective role | 13 |
protein docking | 13 |
i region | 13 |
jhmv replication | 13 |
cytotoxicity assay | 13 |
well characterized | 13 |
response induced | 13 |
tightly regulated | 13 |
allograft nephropathy | 13 |
new insights | 13 |
linked immunosorbent | 13 |
coronavirus nucleocapsid | 13 |
dengue disease | 13 |
effector cell | 13 |
serum antibody | 13 |
transplant center | 13 |
also important | 13 |
marrow transplantation | 13 |
secreting ifn | 13 |
cd nkg | 13 |
specific anti | 13 |
two peptides | 13 |
chronic infection | 13 |
retinoic acid | 13 |
transplantation tolerance | 13 |
genetic studies | 13 |
anchor residue | 13 |
mutant mice | 13 |
beta i | 13 |
dk services | 13 |
mhc interactions | 13 |
autism spectrum | 13 |
four different | 13 |
tcr ligands | 13 |
onto mhc | 13 |
self peptides | 13 |
multiple comparisons | 13 |
murine hepatitis | 13 |
lps stimulation | 13 |
first days | 13 |
cfse lo | 13 |
like proteins | 13 |
expression profiles | 13 |
significantly less | 13 |
cells might | 13 |
conserved region | 13 |
based prediction | 13 |
skin grafts | 13 |
coronary heart | 13 |
pcr amplification | 13 |
also significantly | 13 |
machine learning | 13 |
interstitial tissue | 13 |
free radicals | 13 |
evaluated using | 13 |
cd complex | 13 |
virus may | 13 |
induce class | 13 |
medium containing | 12 |
results provide | 12 |
persistent viral | 12 |
single dose | 12 |
large set | 12 |
viral peptide | 12 |
based approaches | 12 |
producing ifn | 12 |
marker cd | 12 |
transendothelial migration | 12 |
salivary glands | 12 |
data analysis | 12 |
primary response | 12 |
derived dc | 12 |
prediction server | 12 |
antiviral responses | 12 |
infected npcs | 12 |
cells respond | 12 |
bacterial pathogens | 12 |
local immune | 12 |
autoimmune disorders | 12 |
red blood | 12 |
dna binding | 12 |
self mhc | 12 |
testicular function | 12 |
vaccine discovery | 12 |
brain swelling | 12 |
independent manner | 12 |
ctl lines | 12 |
th clones | 12 |
genbank accession | 12 |
vaccines based | 12 |
tcr signaling | 12 |
control cells | 12 |
significantly enhanced | 12 |
host factors | 12 |
donor liver | 12 |
inclusion bodies | 12 |
ii compartment | 12 |
cytoplasmic tail | 12 |
important implications | 12 |
small intestine | 12 |
murine encephalomyelitis | 12 |
first week | 12 |
disease severity | 12 |
ox immunoreactivity | 12 |
conjugated anti | 12 |
fas ligand | 12 |
helper epitopes | 12 |
ge healthcare | 12 |
i supertypes | 12 |
free energy | 12 |
without prior | 12 |
tropical diseases | 12 |
induced demyelination | 12 |
disease activity | 12 |
human igg | 12 |
virus core | 12 |
human fetal | 12 |
brazilian population | 12 |
previously showed | 12 |
costimulatory signals | 12 |
major source | 12 |
iii pi | 12 |
two weeks | 12 |
hla genes | 12 |
term outcome | 12 |
lesser extent | 12 |
kidney graft | 12 |
false discovery | 12 |
causative agent | 12 |
data obtained | 12 |
fluorescence microscopy | 12 |
based mhc | 12 |
humoral rejection | 12 |
may serve | 12 |
low expression | 12 |
immunological tolerance | 12 |
inflammatory protein | 12 |
viral protease | 12 |
effective vaccines | 12 |
electron microscopy | 12 |
relapsing experimental | 12 |
rational design | 12 |
mhc variability | 12 |
regulatory elements | 12 |
significantly associated | 12 |
actin cytoskeleton | 12 |
recently developed | 12 |
may become | 12 |
target gene | 12 |
also able | 12 |
lung transplant | 12 |
point mutations | 12 |
chronic demyelination | 12 |
receptor signaling | 12 |
substrate selection | 12 |
antigen discovery | 12 |
western blots | 12 |
breast milk | 12 |
inflammatory stimuli | 12 |
binding domains | 12 |
year post | 12 |
restricted epitope | 12 |
response may | 12 |
marginal zone | 12 |
future research | 12 |
protease inhibitor | 12 |
mediated autophagy | 12 |
therapeutic interventions | 12 |
cell mhc | 12 |
cell deficient | 12 |
phage display | 12 |
less efficient | 12 |
nucleotide sequences | 12 |
tap transporter | 12 |
adverse events | 12 |
assessed using | 12 |
hla allotypes | 12 |
leukocyte receptor | 12 |
organ transplant | 12 |
immune interferon | 12 |
signal transducer | 12 |
inducible gene | 12 |
processing machinery | 12 |
protective efficacy | 12 |
immunogenic peptides | 12 |
terminal end | 12 |
dengue patients | 12 |
cultured astrocytes | 12 |
selection pressure | 12 |
genetic distance | 12 |
ia antigens | 12 |
antibody formation | 12 |
splenic lymphocytes | 12 |
using elisa | 12 |
cns disease | 12 |
commons license | 12 |
signaling cascades | 12 |
associated proteins | 12 |
novel approach | 12 |
cell dependent | 12 |
dr binding | 12 |
mhc haplotypes | 12 |
strong immune | 12 |
patients compared | 12 |
infection may | 12 |
flow cytometer | 12 |
acidic protein | 12 |
virion infectivity | 12 |
cleavage sites | 12 |
suppressive function | 12 |
hendra virus | 12 |
dna plasmid | 12 |
study provides | 12 |
hla haplotype | 12 |
almost exclusively | 12 |
tongaonkar antigenicity | 12 |
based approach | 12 |
dc subsets | 12 |
vitro culture | 12 |
immature dc | 12 |
cd positive | 12 |
normal human | 12 |
applied biosystems | 12 |
may depend | 12 |
vaccine encoding | 12 |
high throughput | 12 |
classical swine | 12 |
signaling cascade | 12 |
myelin antigens | 12 |
protein vaccine | 12 |
cd deficient | 12 |
quantitative analysis | 12 |
box protein | 12 |
gene conversion | 12 |
immunoglobulin heavy | 12 |
epitope complexes | 12 |
specific inhibition | 12 |
direct effect | 12 |
allogeneic transplantation | 12 |
matrix method | 12 |
viruses may | 12 |
swedish moose | 12 |
different levels | 12 |
treated patients | 12 |
ctl specific | 12 |
also induce | 12 |
vivo studies | 12 |
effector molecules | 12 |
drug discovery | 12 |
peptides spanning | 12 |
fibrillary acidic | 12 |
functional avidity | 12 |
serum albumin | 12 |
tissue destruction | 12 |
statistical significance | 12 |
consensus sequence | 12 |
vitro experiments | 12 |
latent infection | 12 |
increased number | 12 |
productive infection | 12 |
factors involved | 12 |
healthy volunteers | 12 |
membrane glycoprotein | 12 |
tyrosine phosphorylation | 12 |
avium subspecies | 12 |
processing components | 12 |
antigenic sites | 12 |
cytolytic activity | 12 |
newborn mice | 12 |
genome sequences | 12 |
glial fibrillary | 12 |
binding specificity | 12 |
pigeon cytochrome | 12 |
macaque mhc | 12 |
neurological disease | 12 |
map infection | 12 |
tyrosine kinases | 12 |
many studies | 12 |
vasogenic edema | 12 |
monocytic cells | 12 |
clinical data | 12 |
cells present | 12 |
human renal | 12 |
specific binding | 12 |
peptide epitope | 12 |
regulatory protein | 12 |
isolation membrane | 12 |
antigens presented | 12 |
cell entry | 12 |
well tolerated | 12 |
th cell | 12 |
imgt hla | 12 |
foxp mrna | 12 |
protocol biopsies | 12 |
chain gene | 12 |
significantly elevated | 12 |
peptide libraries | 12 |
cells activated | 12 |
inhibitory concentration | 12 |
calcineurin inhibitor | 12 |
blood cd | 12 |
peripheral tolerance | 12 |
porcine dc | 12 |
findings demonstrate | 12 |
cd tc | 12 |
hla molecule | 12 |
skin allograft | 12 |
five different | 12 |
tcr repertoires | 12 |
vascular endothelium | 12 |
kidney donors | 12 |
mice administered | 12 |
hla abs | 12 |
homology modelling | 12 |
ic value | 11 |
transgene expression | 11 |
recipient mice | 11 |
cpg motifs | 11 |
human tumor | 11 |
become activated | 11 |
cerebellar degeneration | 11 |
guinea pigs | 11 |
also possible | 11 |
cells cultured | 11 |
mhc haplotype | 11 |
drinking water | 11 |
nuclear localization | 11 |
transplant tolerance | 11 |
mycoplasma pulmonis | 11 |
putative epitopes | 11 |
htl epitopes | 11 |
stimulate class | 11 |
studies demonstrated | 11 |
rat model | 11 |
proinflammatory cytokine | 11 |
i histocompatibility | 11 |
activated microglia | 11 |
cns inflammation | 11 |
hla antibodies | 11 |
control animals | 11 |
flying fox | 11 |
evidence indicates | 11 |
years post | 11 |
somatic cells | 11 |
seminal plasma | 11 |
colitis model | 11 |
substrate specificity | 11 |
higher binding | 11 |
acid substitution | 11 |
francisella tularensis | 11 |
research institute | 11 |
patients suffering | 11 |
binding data | 11 |
provide new | 11 |
culture conditions | 11 |
vaccine targets | 11 |
human mast | 11 |
peptide antigen | 11 |
protein aggregates | 11 |
highly sensitive | 11 |
driven selection | 11 |
highest number | 11 |
mhc hc | 11 |
developing countries | 11 |
costimulatory molecule | 11 |
also increased | 11 |
matrix protein | 11 |
negative feedback | 11 |
structural features | 11 |
open reading | 11 |
neurodegenerative diseases | 11 |
immune memory | 11 |
mauritian cynomolgus | 11 |
increased production | 11 |
malignant transformation | 11 |
murine macrophages | 11 |
also evaluated | 11 |
default parameters | 11 |
clones derived | 11 |
heart failure | 11 |
species polymorphism | 11 |
lymphocyte reaction | 11 |
available data | 11 |
previously published | 11 |
cellular stress | 11 |
expert system | 11 |
staphylococcus aureus | 11 |
high titers | 11 |
porcine pdc | 11 |
general population | 11 |
surface cd | 11 |
see table | 11 |
strongly suggest | 11 |
epitopes prediction | 11 |
human disease | 11 |
immune mechanisms | 11 |
mice results | 11 |
cell recruitment | 11 |
whole mounts | 11 |
er degradation | 11 |
major cause | 11 |
apoptosis induced | 11 |
cells induced | 11 |
study shows | 11 |
ramachandran plot | 11 |
rejection rate | 11 |
mutation rate | 11 |
renal insufficiency | 11 |
large scale | 11 |
receptor repertoire | 11 |
hiv vaccine | 11 |
population dynamics | 11 |
suppressor cells | 11 |
peptide presented | 11 |
also associated | 11 |
single epitope | 11 |
lysine residues | 11 |
also determined | 11 |
virus nucleoprotein | 11 |
cdr length | 11 |
haemorrhagic fever | 11 |
results may | 11 |
deubiquitinating enzymes | 11 |
stable patients | 11 |
immunoreactive proteins | 11 |
nonhuman primates | 11 |
airway epithelium | 11 |
van der | 11 |
time period | 11 |
infected host | 11 |
significant decrease | 11 |
san diego | 11 |
normal cns | 11 |
reverse transcription | 11 |
years old | 11 |
generation sequencing | 11 |
individual peptides | 11 |
aiv np | 11 |
hpv types | 11 |
uninfected cells | 11 |
cysteine protease | 11 |
fatty acids | 11 |
vice versa | 11 |
ha mer | 11 |
cell sorting | 11 |
mhc epitopes | 11 |
peptide pool | 11 |
binding capacity | 11 |
induced tumors | 11 |
year follow | 11 |
primary astrocytes | 11 |
viral pathogens | 11 |
binding cleft | 11 |
myocardial infarction | 11 |
force field | 11 |
secreted proteins | 11 |
tubular epithelial | 11 |
selected region | 11 |
specific expression | 11 |
enhanced immune | 11 |
southeast asia | 11 |
i mrna | 11 |
west africa | 11 |
mediated induction | 11 |
ligand binding | 11 |
chimeric mhc | 11 |
expression profiling | 11 |
reduced capacity | 11 |
following exposure | 11 |
major psychiatric | 11 |
high number | 11 |
specific tcr | 11 |
tcr contact | 11 |
binding activity | 11 |
days later | 11 |
mouse macrophages | 11 |
tlr expression | 11 |
hla system | 11 |
study group | 11 |
developed countries | 11 |
ii epitope | 11 |
free rats | 11 |
allograft tolerance | 11 |
mouse ifn | 11 |
foxp regulatory | 11 |
derived mhc | 11 |
express high | 11 |
progressive multifocal | 11 |
molecules using | 11 |
immune regulatory | 11 |
normal cellular | 11 |
kidney disease | 11 |
antiviral therapy | 11 |
using two | 11 |
capsid protein | 11 |
green fluorescent | 11 |
classical hla | 11 |
pathogen recognition | 11 |
alloimmune response | 11 |
first two | 11 |
induce apoptosis | 11 |
trained language | 11 |
hla binding | 11 |
selected based | 11 |
peritubular cells | 11 |
immune functions | 11 |
cross presentation | 11 |
solution containing | 11 |
highly effective | 11 |
multifocal leukoencephalopathy | 11 |
cells producing | 11 |
tlr agonists | 11 |
state levels | 11 |
two cell | 11 |
also present | 11 |
fruit bats | 11 |
protein peptides | 11 |
three species | 11 |
high cd | 11 |
docking analysis | 11 |
cells generated | 11 |
ischemia time | 11 |
higher rate | 11 |
high resolution | 11 |
proliferation assays | 11 |
donor cells | 11 |
relatively small | 11 |
one mechanism | 11 |
increased frequency | 11 |
often used | 11 |
response towards | 11 |
cells resulted | 11 |
genetic differences | 11 |
within hours | 11 |
completely inhibited | 11 |
higher risk | 11 |
tracheal mucosa | 11 |
physiological relevance | 11 |
kidney donation | 11 |
may include | 11 |
may cause | 11 |
meld scores | 11 |
large extent | 11 |
heart grafts | 11 |
viral clearance | 11 |
cancer vaccines | 11 |
airway epithelial | 11 |
high incidence | 11 |
severe dengue | 11 |
leader proteins | 11 |
epitope identification | 11 |
protein interaction | 11 |
anchor positions | 11 |
tetanus toxoid | 11 |
immunodominant epitopes | 11 |
calcium influx | 11 |
way anova | 11 |
ifn signal | 11 |
maximal inhibitory | 11 |
precursor frequency | 11 |
soluble factors | 11 |
assay using | 11 |
side properties | 11 |
tcr genes | 11 |
retinal pigment | 11 |
serum antibodies | 11 |
surface glycoprotein | 11 |
type hypersensitivity | 11 |
ibd patients | 11 |
mediated responses | 11 |
dynamics simulation | 11 |
carcinoma cell | 11 |
death receptor | 11 |
two mhc | 11 |
single antigen | 11 |
immune reaction | 11 |
rat astrocytes | 11 |
cellular protein | 11 |
human astrocytes | 11 |
completely understood | 11 |
discovery rate | 11 |
thank dr | 11 |
like viruses | 11 |
sequence variation | 11 |
using anti | 11 |
proteolytic processing | 11 |
infiltrating cd | 11 |
enveloped viruses | 11 |
transmembrane protein | 11 |
patients treated | 11 |
epitope content | 11 |
functional properties | 11 |
blood glucose | 11 |
cold ischemia | 11 |
associated antigens | 11 |
parasite species | 11 |
strong association | 11 |
ii restricted | 11 |
mannose receptor | 11 |
mediated activation | 11 |
inclusion criteria | 11 |
weeks post | 11 |
kidney allografts | 11 |
independent pathway | 11 |
patient tnbc | 11 |
influenza hemagglutinin | 11 |